EOG Resources Inc vs 10X Genomics Inc — how do they compare? EOG Resources Inc trades at $142.49 (market cap $75.22B), while 10X Genomics Inc trades at $58.96 (market cap $7.61B). The key difference: EOG Resources Inc is far larger — about 9.9× 10X Genomics Inc's market cap, and EOG Resources Inc pays a 2.85% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| EOG | TXG | |
|---|---|---|
Market Cap | $75.22B | $7.61B |
Sector | Energy | Health |
52-Week High | $149.89 | $58.57 |
52-Week Low | $101.78 | $11.34 |
Enterprise Value | $78.56B | $7.14B |
Dividend Yield | 2.85% | — |
Signals from Pluang's Aura AI — not financial advice
EOG Resources trades at $142.22, up 5.55% today, with strong earnings beats in recent quarters and a bullish technical signal. The stock shows robust profitability with a 25.81% net income margin and attractive valuation metrics, including a P/E of 11.16. Recent news highlights operational strength and institutional buying interest, supporting positive momentum.
The outlook remains favorable with a consensus price target of $157.88, indicating potential upside. Key risks include oil price volatility and capital expenditure intensity, but disciplined cost controls and shareholder returns provide stability. The stock presents a compelling opportunity for growth-oriented investors seeking energy exposure.
TXG trades at $58.57, up 12.57% in 24 hours, reflecting strong momentum. The stock is technically bullish with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, the company shows improving trends with Q2 2026 earnings beating estimates and revenue growth, yet remains unprofitable with a negative net income margin. Recent news highlights collaborations and acquisitions expanding its genomic capabilities.
Outlook is mixed; analyst consensus is neutral with a $46 price target below current levels, indicating caution despite recent beats. Key risks include sustained losses and competitive pressures, but operational cash flow growth and strategic expansions offer potential upside for patient investors focused on long-term biotech innovation.
Trailing returns across standard periods
Latest headlines on both assets
EOG Resources is an oil and gas producer with acreage in several U.S. shale plays, including the Permian Basin, the Eagle Ford, and the Bakken. At the end of 2021, it reported net proved reserves of 3.7 billion barrels of oil equivalent. Net production averaged 829 thousand barrels of oil equivalent per day in 2021 at a ratio of 72% oil and natural gas liquids and 28% natural gas.
Read more on EOG →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →